GB1195199A - Improvements in Compositions comprising Insulin. - Google Patents
Improvements in Compositions comprising Insulin.Info
- Publication number
- GB1195199A GB1195199A GB5275666A GB5275666A GB1195199A GB 1195199 A GB1195199 A GB 1195199A GB 5275666 A GB5275666 A GB 5275666A GB 5275666 A GB5275666 A GB 5275666A GB 1195199 A GB1195199 A GB 1195199A
- Authority
- GB
- United Kingdom
- Prior art keywords
- insulin
- compositions
- nov
- compound
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Abstract
1,195,199. Insulin preparations. HORLICKS PHARMACEUTICALS Ltd. 22 Nov., 1967 [25 Nov., 1966], No. 52756/66. Heading A5B. Hypoglycaemic compositions comprise an insulin compound and a compound of the formula: wherein A is a C 1-8 straight or branched aliphatic chain and R<SP>1</SP> is hydroxy, C 1-3 alkoxy, aralkoxy, aryloxy which may carry halogen or alkoxy groups, an amino group or a mono- or dialkylamino or alkyleneimino group and/or salts thereof. Any conventional insulin may be used, e.g. amorphous or crystallime zinc insulin or N-acyl insulin and the compositions may be in forms for rectal or parenteral administration.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5275666A GB1195199A (en) | 1966-11-25 | 1966-11-25 | Improvements in Compositions comprising Insulin. |
BE706700D BE706700A (en) | 1966-11-25 | 1967-11-17 | |
ES347563A ES347563A1 (en) | 1966-11-25 | 1967-11-24 | Improvements in Compositions comprising Insulin. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5275666A GB1195199A (en) | 1966-11-25 | 1966-11-25 | Improvements in Compositions comprising Insulin. |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1195199A true GB1195199A (en) | 1970-06-17 |
Family
ID=10465171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5275666A Expired GB1195199A (en) | 1966-11-25 | 1966-11-25 | Improvements in Compositions comprising Insulin. |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE706700A (en) |
ES (1) | ES347563A1 (en) |
GB (1) | GB1195199A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2282874A1 (en) * | 1974-08-27 | 1976-03-26 | Stanley Drug Products Inc | Antibacterial omega guanidino acids - useful for treating bacterial and coccic infections |
FR2368959A1 (en) * | 1976-11-02 | 1978-05-26 | Beecham Group Ltd | COMPOSITIONS CONTAINING GUANIDINOALCANOIC ACID DERIVATIVES, USED AS A MEDICINAL PRODUCT |
US5132324A (en) * | 1990-02-28 | 1992-07-21 | The Upjohn Company | Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (niddm) |
US5599841A (en) * | 1990-02-28 | 1997-02-04 | The Upjohn Company | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
US5900435A (en) * | 1991-08-26 | 1999-05-04 | Pharmacia & Upjohn Company | Composition, food product and uses of 3-guanidinopropionic acid |
US6008253A (en) * | 1991-08-26 | 1999-12-28 | The Upjohn Company | Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal |
US6075031A (en) * | 1995-10-11 | 2000-06-13 | Dana-Farber Cancer Institute | Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders |
WO2006092298A1 (en) * | 2005-03-04 | 2006-09-08 | Alzchem Trostberg Gmbh | Salts, addition compounds and complex compounds of guanidinoacetic acid |
US8536222B2 (en) | 2005-03-04 | 2013-09-17 | Alzchem Ag | Addition compounds of guanidinoacetic acid |
-
1966
- 1966-11-25 GB GB5275666A patent/GB1195199A/en not_active Expired
-
1967
- 1967-11-17 BE BE706700D patent/BE706700A/xx unknown
- 1967-11-24 ES ES347563A patent/ES347563A1/en not_active Expired
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2282874A1 (en) * | 1974-08-27 | 1976-03-26 | Stanley Drug Products Inc | Antibacterial omega guanidino acids - useful for treating bacterial and coccic infections |
FR2368959A1 (en) * | 1976-11-02 | 1978-05-26 | Beecham Group Ltd | COMPOSITIONS CONTAINING GUANIDINOALCANOIC ACID DERIVATIVES, USED AS A MEDICINAL PRODUCT |
US5132324A (en) * | 1990-02-28 | 1992-07-21 | The Upjohn Company | Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (niddm) |
US5134164A (en) * | 1990-02-28 | 1992-07-28 | The Upjohn Company | Use of 3-guanidinopropionic acid in the treatment of excess adiposity |
US5599841A (en) * | 1990-02-28 | 1997-02-04 | The Upjohn Company | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
US5900435A (en) * | 1991-08-26 | 1999-05-04 | Pharmacia & Upjohn Company | Composition, food product and uses of 3-guanidinopropionic acid |
US6008253A (en) * | 1991-08-26 | 1999-12-28 | The Upjohn Company | Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal |
US6075031A (en) * | 1995-10-11 | 2000-06-13 | Dana-Farber Cancer Institute | Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders |
WO2006092298A1 (en) * | 2005-03-04 | 2006-09-08 | Alzchem Trostberg Gmbh | Salts, addition compounds and complex compounds of guanidinoacetic acid |
US8153685B2 (en) | 2005-03-04 | 2012-04-10 | Alzchem Trostberg Gmbh | Salts, addition compounds and complex compounds of guinadinoacetic acid |
US8536222B2 (en) | 2005-03-04 | 2013-09-17 | Alzchem Ag | Addition compounds of guanidinoacetic acid |
Also Published As
Publication number | Publication date |
---|---|
ES347563A1 (en) | 1969-02-01 |
BE706700A (en) | 1968-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1147379A (en) | 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts | |
GB1195199A (en) | Improvements in Compositions comprising Insulin. | |
GB1178563A (en) | Preparations containing Urea or Thiourea Derivatives for use as Molluscicides | |
GB1154743A (en) | Aminoethanols | |
GB1153578A (en) | Phenyl-Isopropylamine Derivatives | |
GB1171156A (en) | Improvements in or relating to Cycloalkane Derivatives and the Manufacture thereof | |
GB1290818A (en) | ||
GB1153424A (en) | Pharmaceutical Compositions | |
GB1195200A (en) | Pharmaceutical Compositions. | |
ES8407011A1 (en) | Derivatives of A-21978C cyclic peptides | |
GB1518042A (en) | Oxadiazolinone derivatives | |
ES375079A1 (en) | 3-alkoxy-or 3-aryloxy-2-(diaryl-hydroxy)-methyl-propylamines | |
GB1250348A (en) | ||
GB1290841A (en) | ||
GB1050565A (en) | ||
GB1387803A (en) | Watersoluble salts of polyhydroxyphenylchromanones | |
GB1131727A (en) | Antidepressant n,n-dimethylcinnamamide compositions | |
GB1227365A (en) | ||
GB1073521A (en) | Indole derivatives | |
GB1132397A (en) | Improvements in or relating to fluorene derivatives and the manufacture thereof | |
GB1187071A (en) | N-Amino-Substituted 4-Anilino-Pyridines | |
GB1395929A (en) | Thioureas | |
GB1172696A (en) | Phenyl-Indandione Derivatives | |
GB1250279A (en) | ||
GB1208116A (en) | 0-(substituted)-5-aminotetrazoles and treatment of the animal organism therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLE | Entries relating assignments, transmissions, licences in the register of patents | ||
PLNP | Patent lapsed through nonpayment of renewal fees |